The percentage of mixed chimerism and the proportion of CD4-positive cells to GFP-positive cells after HPC transplantation
| . | . | Days after HPC transplantation . | . |
|---|---|---|---|
| Cells | 14 | 56 | 100 |
| Peripheral blood | |||
| HPC-derived GFP positive | 55.4 ± 24.3 | 28.0 ± 22.3 | 48.4 ± 40.4 |
| CD45/GFP positive | 97.5 ± 0.9 | 98.0 ± 1.7 | 99.4 ± 0.6 |
| Spleen | |||
| HPC-derived GFP positive | 91.2 | 23.4 ± 8.8 | 15.4 ± 0.01 |
| CD45/GFP positive | 49.6 | 86.4 ± 15.6 | 92.9 ± 5.8 |
| Bone marrow | |||
| HPC-derived GFP positive | 94.3 | 23.3 ± 20.1 | 31.5 ± 36.7 |
| CD45/GFP positive | 85.3 | 91.1 ± 8.6 | 94.8 ± 5.2 |
| . | . | Days after HPC transplantation . | . |
|---|---|---|---|
| Cells | 14 | 56 | 100 |
| Peripheral blood | |||
| HPC-derived GFP positive | 55.4 ± 24.3 | 28.0 ± 22.3 | 48.4 ± 40.4 |
| CD45/GFP positive | 97.5 ± 0.9 | 98.0 ± 1.7 | 99.4 ± 0.6 |
| Spleen | |||
| HPC-derived GFP positive | 91.2 | 23.4 ± 8.8 | 15.4 ± 0.01 |
| CD45/GFP positive | 49.6 | 86.4 ± 15.6 | 92.9 ± 5.8 |
| Bone marrow | |||
| HPC-derived GFP positive | 94.3 | 23.3 ± 20.1 | 31.5 ± 36.7 |
| CD45/GFP positive | 85.3 | 91.1 ± 8.6 | 94.8 ± 5.2 |
Values are percentages, and data presented as means plus or minus SD indicates more than 3 mice per group.